Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

ClinicalTrials.gov ID: NCT02395172

Public ClinicalTrials.gov record NCT02395172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Open-Label, Multicenter Trial of Avelumab (MSB0010718C) Versus Docetaxel in Subjects With Non-Small Cell Lung Cancer That Has Progressed After a Platinum-Containing Doublet

Study identification

NCT ID
NCT02395172
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono Research & Development Institute, Inc.
Industry
Enrollment
792 participants

Conditions and interventions

Interventions

  • Avelumab Drug
  • Docetaxel Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2015
Primary completion
Nov 21, 2017
Completion
Dec 2, 2019
Last update posted
Aug 2, 2020

2015 – 2019

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
University of Alabama Tuscaloosa Alabama 35401
Mayo Clinic Scottsdale , Phoenix Arizona 85259-5499
Pacific Cancer Medical Center, Inc. Anaheim California 92801
Healing Hands Oncology and Medical Care Lawndale California 90260
Sutter Gould Medical Foundation Modesto California 95355
Sharp Memorial Hospital San Diego California 92123
Lynn Cancer Institute Center Boca Raton Florida 33486
University Cancer Institute Boynton Beach Florida 33426
Holy Cross Hospital Inc. Fort Lauderdale Florida 33308
Florida Cancer Specialists-Broadway Fort Myers Florida 33916
Florida Cancer Specialists St. Petersburg Florida 33705
Florida Cancer Specialists West Palm Beach Florida 33401
Northeast Georgia Cancer Care, LLC Athens Georgia 30607
Metairie Oncologist, LLC Metairie Louisiana 70006
Henry Ford Health System Detroit Michigan 48202
Hematology Oncology Associates of Rockland Nyack New York 10960
Novant Health Oncology Specialists Winston-Salem North Carolina 27103
Oncology Hematology Care Cincinnati Ohio 45242
Signal Point Clinical Research Center Middletown Ohio 45042
Mercy Clinic Oklahoma Communities, Inc. Oklahoma City Oklahoma 73120-9309
Abington Memorial Hospital Abington Pennsylvania 19001
Penn State Univ. Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Center for Biomedical Research, LLC Knoxville Tennessee 37909
SCRI - Tennessee Oncology Nashville Tennessee 37203
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
University of Texas Health Science Center at Tyler Tyler Texas 75708
MultiCare Health System Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 233 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02395172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2020 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02395172 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →